Teucrium’s proposed short XRP exchange-traded fund (ETF) has reportedly been delayed for the 19th time, according to unconfirmed reports circulating on September 14, 2026. The underlying filing text could not be independently reviewed, and key details of the reported postponement remain unverified. CoinWy reported the development.

The reported product is designed to seek returns opposite to XRP’s price movement. The headline attributes the 19th delay to Teucrium but does not provide a revised date. No accessible filing body confirms either the delay count or the reason for the postponement.

What Is Confirmed About the Reported Delay

The claim of a 19th delay comes from a single headline tip and should be treated as unconfirmed. No complete chronology of amendments to the fund’s effective date was available for review, meaning the specific count cannot be established from the accessible evidence.

Some details can be confirmed through official filing metadata. SEC search records list a September 11, 2026, Form 485BXT for Listed Funds Trust under accession number 0000894189-26-025151. The filing uses the document name teucrium485bxt2xshortxrp.htm, and the document is available through SEC EDGAR. The same search response lists an earlier Form 485BXT dated August 14, 2026, with the same short-XRP document name.

Those metadata entries identify filings but do not establish whether the Securities and Exchange Commission approved or rejected the product, or why any postponement occurred. The available information also does not identify which deadline may have changed or when trading could begin. CoinWy has separately tracked the effectiveness timeline for Teucrium’s 2x short fund as additional filings have appeared.

How a Short XRP ETF Is Intended to Work

A short ETF generally seeks gains when its reference asset or benchmark declines, while exposing investors to potential losses when that asset rises. This objective is the inverse of ordinary long exposure, which seeks gains as the reference asset increases.

The proposed fund references XRP. However, the headline’s “ripple:native” wording should not be interpreted as an official product name. No prospectus, investment objective, leverage multiple, daily reset policy, fee schedule, or ticker for the short fund could be verified from the accessible sources.

For context, Teucrium describes its existing XXRP product as the Teucrium 2x Long Daily XRP ETF. The issuer says the fund seeks two times XRP’s daily price performance before fees and expenses. Teucrium also states that XXRP obtains its XRP exposure primarily through derivatives rather than by holding physical XRP. Those disclosures apply to the long fund and cannot be assumed to define the proposed short product’s final strategy.

What Remains Unconfirmed

The revised deadline, the nature of the postponement, and the reason for it remain unresolved. No issuer statement, regulatory order, or confirmed launch date supports the reported figure of 19 delays.

Verifying the count and constructing an accurate timeline would require an accession-by-accession review of dated extension filings. That review would also need to distinguish among a filing’s effective date, any regulatory decision, and the actual start of exchange trading, because those events can occur at different times.

Market data does not provide a direct explanation for the reported filing activity. XRP traded at about $1.40, up approximately 4.4% on the day, while the crypto Fear & Greed Index stood at 57, classified as “Greed,” on September 14, 2026. Those readings reflect broader market conditions and cannot be attributed to the ETF filing. The same limitation applies to broader developments involving XRP-linked products and expectations surrounding the September 16 Fed vote.

This article is for informational purposes only and does not constitute financial or investment advice. Cryptocurrency and digital asset markets carry significant risk. Readers should conduct their own research before making decisions.